Sonoma Biotherapeutics
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system.
B2X
Company Operating Status
Active
Country
Crunchbase URL
Email Address
partnerships@sonomabio.com
0
media@sonomabio.com
info@sonomabio.com
Full Address
201 Haskins Way, Suite 203 South San Francisco, CA 94080, United States
410 W Harrison St, Suite 300 Seattle, WA 98119, United States
Latest Funding Round Date
September 4, 2024
Latest Funding Round Amount (USD)
45,000,000
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
51 – 200
0
Pitchbook URL
Total Funding Amount (USD)
340,000,000
Twitter URL
Official Website
Find more companies like Sonoma Biotherapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.